Study of XB010 in Subjects With Solid Tumors

Clinical trial NCT06545331 · RECRUITING

Trial details

NCT number: NCT06545331
Sponsor: Exelixis
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Esophageal Squamous Cell Cancer Head and Neck Squamous Cell Cancer NSCLC (Non-small Cell Lung Cancer)Hormone-receptor-positive Breast Cancer Triple Negative Breast Cancer (TNBC)

Start date: 2024-08-06
Primary completion: 2026-11-23
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.